Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NVDANYSE:NVONASDAQ:RENTNASDAQ:SCWONASDAQ:SKYENASDAQ:SPWR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNVDANVIDIA$159.28+1.3%$136.38$86.62▼$160.98$3.89T2.13268.14 million shs143.72 million shsNVONovo Nordisk A/S$69.05-1.1%$69.96$57.00▼$143.69$308.84B0.647.25 million shs4.05 million shsRENTRent the Runway$5.18-0.3%$5.44$3.69▼$19.86$20.47M1.3881,174 shs17,470 shsSCWO374Water$0.21+7.9%$0.35$0.16▼$1.99$29.86M-0.22556,322 shs851,619 shsSKYESkye Bioscience$4.58+9.7%$2.57$1.14▼$7.47$142.79M1.95498,072 shs947,978 shsSPWRCSLM Acquisition$2.05+5.1%$1.69$1.06▼$3.37$164.56M0.791.54 million shs1.11 million shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNVDANVIDIA+1.29%+2.75%+12.79%+68.89%+24.17%NVONovo Nordisk A/S-1.09%+1.87%-2.61%+10.34%-50.36%RENTRent the Runway-0.29%+5.18%-17.07%+12.50%-64.87%SCWO374Water+7.89%-49.41%-54.46%-25.48%-81.02%SKYESkye Bioscience+9.71%+7.65%+97.54%+249.50%-38.67%SPWRCSLM Acquisition+5.13%+16.48%+13.57%+49.64%+65.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNVDANVIDIA4.888 of 5 stars3.55.01.73.02.82.51.9NVONovo Nordisk A/S4.7054 of 5 stars4.15.02.50.02.30.03.1RENTRent the Runway1.9327 of 5 stars3.33.00.00.00.62.50.0SCWO374Water0.438 of 5 stars0.01.00.00.01.73.30.0SKYESkye Bioscience2.3006 of 5 stars3.54.00.00.02.50.00.0SPWRCSLM Acquisition4.0941 of 5 stars3.30.00.04.41.14.20.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNVDANVIDIA 2.93Moderate Buy$176.1910.62% UpsideNVONovo Nordisk A/S 2.27Hold$112.0062.20% UpsideRENTRent the Runway 2.50Moderate Buy$33.00537.68% UpsideSCWO374Water 0.00N/AN/AN/ASKYESkye Bioscience 3.00Buy$16.60262.84% UpsideSPWRCSLM Acquisition 2.50Moderate Buy$6.00192.68% UpsideCurrent Analyst Ratings BreakdownLatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025NVDANVIDIAMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$170.00 ➝ $185.006/27/2025SCWO374WaterWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)6/25/2025NVDANVIDIALoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$175.00 ➝ $250.006/24/2025SKYESkye BioscienceJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$15.006/17/2025NVDANVIDIABarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$170.00 ➝ $200.006/16/2025NVDANVIDIAOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$175.006/11/2025SCWO374WaterWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)5/29/2025NVDANVIDIAWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/29/2025NVDANVIDIAMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$160.00 ➝ $170.005/29/2025NVDANVIDIACitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$150.00 ➝ $180.005/29/2025NVDANVIDIABarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$155.00 ➝ $170.00(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNVDANVIDIA$130.50B29.78$3.06 per share52.11$3.44 per share46.30NVONovo Nordisk A/S$42.12B7.32$3.89 per share17.73$4.66 per share14.82RENTRent the Runway$306.20M0.07$4.07 per share1.27($52.02) per share-0.10SCWO374Water$440K67.41N/AN/A$0.12 per share1.71SKYESkye BioscienceN/AN/AN/AN/A$2.25 per shareN/ASPWRCSLM Acquisition$108.74M1.51N/AN/A($1.32) per share-1.55Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNVDANVIDIA$72.88B$3.1051.3840.021.4151.69%105.09%72.19%8/27/2025 (Estimated)NVONovo Nordisk A/S$14.64B$3.3820.4314.821.3534.52%80.94%24.23%8/6/2025 (Estimated)RENTRent the Runway-$69.90M-$19.13N/AN/AN/A-24.60%N/A-29.77%9/4/2025 (Estimated)SCWO374Water-$12.43M-$0.10N/A∞N/A-2,093.18%-119.57%-98.25%8/13/2025 (Estimated)SKYESkye Bioscience-$26.57M-$0.82N/AN/AN/AN/A-53.92%-48.58%N/ASPWRCSLM Acquisition-$56.45MN/A0.00N/AN/A-21.35%-8.47%8.23%N/ALatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/5/2025Q1 2026RENTRent the Runway-$7.43-$6.58+$0.85-$6.58$68.70 million$69.60 million5/28/2025Q1 2026NVDANVIDIA$0.87$0.81-$0.06$0.76$43.09 billion$44.06 billion5/15/2025Q1 2025SCWO374Water-$0.02-$0.03-$0.01-$0.03$0.10 million$0.54 million5/8/2025Q1 2025SKYESkye Bioscience-$0.31-$0.28+$0.03-$0.28N/AN/A5/7/2025Q1 2025NVONovo Nordisk A/S$0.92$0.92N/A$0.92N/A$11.87 billion4/15/2025Q4 2025RENTRent the Runway-$3.48-$3.44+$0.04-$3.44$77.60 million$76.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNVDANVIDIA$0.040.03%N/A1.29%1 YearsNVONovo Nordisk A/S$1.642.38%N/A48.52%N/ARENTRent the RunwayN/AN/AN/AN/AN/ASCWO374WaterN/AN/AN/AN/AN/ASKYESkye BioscienceN/AN/AN/AN/AN/ASPWRCSLM AcquisitionN/AN/AN/AN/AN/ALatest RENT, NVDA, SPWR, SCWO, NVO, and SKYE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025NVDANVIDIAquarterly$0.010.03%6/11/20256/11/20257/3/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNVDANVIDIA0.103.392.96NVONovo Nordisk A/S0.700.740.56RENTRent the RunwayN/A1.221.22SCWO374WaterN/A4.073.41SKYESkye BioscienceN/A11.8511.85SPWRCSLM AcquisitionN/A1.191.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNVDANVIDIA65.27%NVONovo Nordisk A/S11.54%RENTRent the Runway73.10%SCWO374Water12.16%SKYESkye Bioscience21.09%SPWRCSLM Acquisition47.36%Insider OwnershipCompanyInsider OwnershipNVDANVIDIA4.17%NVONovo Nordisk A/S0.07%RENTRent the Runway8.53%SCWO374Water20.30%SKYESkye Bioscience4.50%SPWRCSLM Acquisition32.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNVDANVIDIA36,00024.40 billion23.38 billionOptionableNVONovo Nordisk A/S77,3494.47 billion4.46 billionOptionableRENTRent the Runway1,0533.98 million3.64 millionOptionableSCWO374Water20144.68 million115.31 millionNot OptionableSKYESkye Bioscience1130.98 million29.58 millionOptionableSPWRCSLM Acquisition15180.27 million54.34 millionNot OptionableRENT, NVDA, SPWR, SCWO, NVO, and SKYE HeadlinesRecent News About These CompaniesSunPower Joins the Russell 3000 & Russell Microcap IndicesJune 30, 2025 | globenewswire.comCSLM Digital Asset Acquisition Files for IPOJune 18, 2025 | marketwatch.comHas CSLM Acquisition Corp. (SPWR) Outpaced Other Oils-Energy Stocks This Year?June 12, 2025 | zacks.comCEO T.J. Rodgers on Solar ITC Loss - The Globe and MailJune 10, 2025 | theglobeandmail.comAnalysts Set Expectations for SPWR FY2026 EarningsJune 10, 2025 | marketbeat.comCEO T.J. Rodgers on Solar ITC LossJune 9, 2025 | globenewswire.comThurman J. Rodgers Purchases 21,177 Shares of Complete Solaria, Inc. (NASDAQ:SPWR) StockJune 6, 2025 | insidertrades.comComplete Solaria (NASDAQ:SPWR) Stock Price Down 5.4% - Here's What HappenedJune 6, 2025 | marketbeat.comThurman J. Rodgers Purchases 606,000 Shares of Complete Solaria, Inc. (NASDAQ:SPWR) StockJune 5, 2025 | marketbeat.comChairman and CEO TJ Rodgers buys 300,000 shares of Complete SolariaJune 5, 2025 | msn.comComplete Solaria (NASDAQ:SPWR) Downgraded by Wall Street Zen to HoldJune 5, 2025 | marketbeat.comInsider Buying: Complete Solaria, Inc. (NASDAQ:SPWR) CEO Acquires 21,177 Shares of StockJune 5, 2025 | marketbeat.comCEO Thanks Shareholders for Ongoing SupportMay 30, 2025 | globenewswire.comComplete Solaria Delays Q1 2025 Financial ReportMay 14, 2025 | tipranks.comWhy Complete Solaria, Inc.’s (SPWR) Stock Is Down 5.03%May 5, 2025 | aaii.comAComplete Solaria announces strategic vision updateApril 23, 2025 | uk.investing.comComplete Solaria announces rebrand as SunPowerApril 21, 2025 | markets.businessinsider.comComplete Solaria, Inc. Announces Rebrand as SunPowerApril 21, 2025 | gurufocus.comComplete Solaria, Inc. Announces Rebrand as SunPower | CSLR Stock NewsApril 21, 2025 | gurufocus.comComplete Solaria, Inc. Announces Rebrand as SunPowerApril 21, 2025 | globenewswire.comComplete Solar to Report 2024 and Q1’25 on April 30April 18, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesNVIDIA’s Stock Price Hits New Highs: This Is What’s NextBy Thomas Hughes | June 26, 2025View NVIDIA’s Stock Price Hits New Highs: This Is What’s NextWhy Nebius Group Is One of the Top AI Stocks to WatchBy Thomas Hughes | June 17, 2025View Why Nebius Group Is One of the Top AI Stocks to WatchRKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?3 Blockchain Stocks to Profit in a Decentralized WorldBy Chris Markoch | June 24, 2025View 3 Blockchain Stocks to Profit in a Decentralized WorldS&P 500 All-Time Highs: 5 Catalysts Driving It HigherBy Thomas Hughes | June 30, 2025View S&P 500 All-Time Highs: 5 Catalysts Driving It HigherRENT, NVDA, SPWR, SCWO, NVO, and SKYE Company DescriptionsNVIDIA NASDAQ:NVDA$159.28 +2.03 (+1.29%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$159.22 -0.06 (-0.04%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Novo Nordisk A/S NYSE:NVO$69.05 -0.77 (-1.10%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$69.12 +0.08 (+0.11%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.Rent the Runway NASDAQ:RENT$5.18 -0.02 (-0.29%) Closing price 07/3/2025 03:09 PM EasternExtended Trading$5.18 0.00 (0.00%) As of 07/3/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rent the Runway, Inc. operates shared designer closet in the United States. The company offers evening wear and accessories, ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear under subscription, rental, and resale offering. It also engages in the software development and support activities. Rent the Runway, Inc. was incorporated in 2009 and is headquartered in Brooklyn, New York.374Water NASDAQ:SCWO$0.20 +0.02 (+7.89%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$0.20 0.00 (0.00%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.374Water Inc. provides a technology that transforms wet wastes into recoverable resources in the United States. The company transforms wet wastes, including sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals. It offers AirSCWO systems, a waste stream treatment system based on supercritical water oxidation that are used to treat various hazardous and non-hazardous waste streams. It serves Industrial, agricultural, defense, oil and gas, waste management, sanitation project, environmental remediation and compliance, and municipal markets. 374Water Inc. is based in Durham, North Carolina.Skye Bioscience NASDAQ:SKYE$4.58 +0.41 (+9.71%) Closing price 07/3/2025 03:56 PM EasternExtended Trading$4.58 0.00 (0.00%) As of 07/3/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Skye Bioscience, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.CSLM Acquisition NASDAQ:SPWR$2.05 +0.10 (+5.13%) As of 07/3/2025 01:00 PM EasternComplete Solaria, Inc. engages in the provision of solar services. It offers sales enablement, project management, partner coordination, and customer communication. The company is headquartered in San Ramon, CA and does business as SunPower Corporation. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
